New radiation approach aims to safely target returning prostate cancer
NCT ID NCT01923506
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a high-precision radiation treatment called stereotactic body radiation therapy (SBRT) for men whose prostate cancer has returned after surgery. The main goal is to find the safest dose by monitoring side effects in 26 participants. The treatment delivers focused X-rays directly to the tumor area to reduce damage to healthy tissue.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Glowing dye could light up hidden lymph nodes in prostate cancer surgery
- New PET scan technique could map hidden prostate cancer recurrences
- Immune-Boosting drug and vaccine aim to fight returning prostate cancer
- Could a depression drug fight prostate cancer?
- Scientists dig into prostate Cancer's surroundings for clues
- Glow-in-the-Dark antibody could help surgeons spot prostate cancer